Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients

Blood-direct InvaderPlus® as a new method for genetic testing

(2012) Akira Hirasawa et al.   Personalized Medicine

Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysis

(2012) Mafalda M Dias et al.   PHARMACOGENOMICS

Dose-Dependent Association between UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Low Doses Also Increase Risk

(2010) Z.-Y. Hu et al.   CLINICAL CANCER RESEARCH

Irinotecan pharmacogenomics

(2010) Sharon Marsh et al.   PHARMACOGENOMICS

An overview of the recent progress in irinotecan pharmacogenetics

(2010) Yutaka Fujiwara et al.   PHARMACOGENOMICS

Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers

(2009) Masashi Takano et al.   ONCOLOGY

Pharmacogenetics of Gilbert’s syndrome

(2008) Christian P Strassburg   PHARMACOGENOMICS